https://www.eurekalert.org/news-releases/945033
News Release 1-Mar-2022
CDC study provides real-world information on vaccine effectiveness in 5- to 11-year-olds
Peer-Reviewed Publication
Regenstrief Institute
Using data from 10 states, a study from the U.S. Centers for Disease Control and Prevention (CDC) is one of the first real-world studies to show that two doses of an mRNA vaccine provide protection against COVID-19 associated emergency department and urgent care visits among children ages 5 to 11.
The study also found that two doses of an mRNA vaccine provide protection against COVID-19 associated emergency department and urgent care visits as well as very high protection against hospitalization among adolescents aged 12 to 17.
-----
No comments:
Post a Comment